National Brain Research Centre

Last updated

National Brain Research Centre
National Brain Research Centre (Gurgaon, Haraya, India).jpg
TypeAutonomous Government Institute (Deemed University)
Established1997;27 years ago (1997)
President Minister of Science and Technology, Government of India
DirectorKrishanu Ray
Location
Manesar, Gurugram
,
Haryana
,
India
CampusSemi-Urban
Website www.nbrc.ac.in
National Brain Research Centre logo.jpg

National Brain Research Centre is a research institute in Manesar, Gurugram, India. It is an autonomous institute under the Department of Biotechnology, Ministry of Science and Technology, Government of India. [1] The institute is dedicated to research in neuroscience and brain functions in health and diseases using multidisciplinary approaches. This is the first autonomous institute by DBT to be awarded by the Ministry of Education, Government of India, formerly known as the Ministry of Human Resource Development, in May 2002. NBRC (National Brain Research Centre) was dedicated to the nation by the Honorable President of India Dr. A.P.J. Abdul Kalam in December 2003. [2] The founder chairman of NBRC Society is Prof. Prakash Narain Tandon, whereas the founder director Prof. Vijayalakshmi Ravindranath was followed by Prof. Subrata Sinha and Prof. Neeraj Jain. The current director of NBRC is Prof. Krishanu Ray.

Contents

The National Brain Research Centre (NBRC) is India's only institute dedicated to neuroscience research and education. The institute's primary objectives are to understand brain functions in both healthy and diseased states, train human resources capable of conducting interdisciplinary research in neuroscience, and promote neuroscience in India by networking with national institutions. Scientists and students at NBRC come from diverse academic backgrounds, including biological, computational, mathematical, physical, engineering, and medical sciences.

History

On 5 October 1995, the proposal for founding NBRC was put forward. The creation was subsequently declared on 14 November 1997 as a part of the Golden Jubilee celebrations of India's Independence and the birth date of the former Prime Minister, Jawaharlal Nehru. [3] A Management Advisory Committee was further formed. In 2000, the institute commenced functioning as an autonomous institute of the Department of Biotechnology from its temporary location at International Centre for Genetic Engineering and Biotechnology, New Delhi. NBRC was awarded the status of Deemed University by Ministry of Education in 2002. On 16 December 2003, NBRC was moved to the foothills of the Aravalli Range in Manesar.

In the year 2006, National Neuroimaging facility was established that was fully equipped with state-of-the-art equipment, such as a 3 tesla magnetic resonance imaging scanner, electroencephalography, and evoked potential recording. In the following year, a Translational and Clinical Neuroscience Unit was formed along with a Neurology Outpatient Department to Civil Hospital, Gurgaon, to help common people and assess the occurrence of neurological cases in this region. Further, the Centre of Excellence for Epilepsy, jointly administered by NBRC and All India Institute of Medical Sciences, was established in 2005. Two major flagship programs by NBRC were initiated in the past few years. By 2017, National Dementia Program was initiated under NBRC's leadership, whereas by 2019, a flagship program entitled "Comparative mapping of common mental disorders (CMD) over the lifespan" was launched to understand the science of well-being.

Academics

NBRC has integrated multidisciplinary teaching programmes in Life Sciences, such as 2-year M.Sc. program in Neuroscience with broad overview of different aspects of Neuroscience. Eligibility criteria:

  1. Bachelor's degree or equivalent in any branch of science such as Life Sciences / Physics / Chemistry / Mathematics / Statistics / Computer applications / Pharmacy / Veterinary Science / Psychology / Engineering / Technology / Medicine from a recognized Institute / University
  2. Candidates appearing for the final year of the qualifying examination are also eligible to apply
  3. Minimum 55% (50% for SC / ST / PH candidates) marks or equivalent grade or grade point average from secondary (10th) examination onwards is required. Candidates should calculate their percentage up to two decimal points to determine their eligibility

NBRC offers 5-year Ph.D. program in Neuroscience to students from diverse backgrounds who have a master's degree in any branch related to Neuroscience as mentioned below: Eligibility criteria:

  1. Master's degree or equivalent in any branch of science, such as Life Sciences / Physics / Chemistry / Mathematics / Statistics / Computer applications / Pharmacy / Veterinary Science / Psychology from a recognized Institute / University
  2. Students who have done a minimum of four-years of course-work leading to a bachelor's degree or equivalent in Engineering / Technology / Medicine from a recognized Institute / University
  3. Candidates appearing for the final year of the qualifying examination are also eligible to apply
  4. Minimum 55% (50% for SC / ST / PH candidates) marks or equivalent grade or grade point average from the secondary (10th) examination onwards is required. Candidates should calculate their percentage up to two decimal points to determine their eligibility

NBRC conducts summer training programs wherein trainees attend seminars and journal clubs organized at the institute and get exposure to neuroscience.

Research

Research faculty studies the complexities of brain functions and cognition in health and diseases. Research at NBRC is organized into five divisions: 1) Cellular neuroscience and Molecular neuroscience, 2) Systems neuroscience, 3) Cognitive neuroscience, 4) Computational neuroscience, and 5) Translational neuroscience. Nevertheless, faculty collaborates across divisions and other scientists. Research develops therapeutic tools and platforms to assess and cure brain disorders, including Alzheimer's disease, Parkinson's disease, dementia, Japanese encephalitis, Zika virus disease, NeuroAIDS, brain tumor, spinal cord injury, and stroke. The research focuses on detailed understanding of our senses of touch, hearing, speech learning, memory, and spatial navigation. Moreover, basic research helps plan clinical trials for the development of rational therapy for brain disorders. Researchers have also been studying the implications of SARS-CoV-2 on the brain.

Major research programmes

  1. Dementia Science Program: This is a national level multi-centric program that provides insights into the prevalence of dementia and discover biomarkers, risk factors, and protective factors. These factors play a major role in the conversion of MCI to dementia among elderly. For the diagnosis and classification of dementia, all centers use robust uniform criteria that are internationally accepted, adapted, and validated in the Indian context. Findings could help formulate national-level policies for understanding and treating MCI in elderly.
  2. Comparative mapping of common mental disorders (CMD) over the lifespan: This flagship program understands how information-processing networks in the brain are affected in CMD, including anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder. The program also studies underlying brain mechanisms that differentiate between these disorders, and whether these networks are affected in the same manner in different age groups.

Technological advancement

Major research breakthroughs

Scientists have been studying the early biomarkers for AD using brain chemicals. Monitoring glutathione (GSH), an antioxidant molecule in the brain, aids in the early identification of AD and mapping out therapeutic invention. Scientists have demonstrated that hippocampus, frontal, and cingulate cortical regions responsible for memory and higher cognitive functions, respectively, show significant GSH depletion, leading to cognitive decline. [19] Using 31P MRS, scientists discovered that pH of the left hippocampal formation in AD shifts towards alkalinity. [20] Research has also demonstrated the existence of two open-and-closed conformations of GSH in healthy young participants. Presently, they are investigating the role of two GSH conformations and link between iron deposition and oxidative stress (OS) in the hippocampal formation in AD. [21] Although the exact cause of AD remains unknown, OS is considered a potential factor. Additionally, researchers at NBRC have proposed a novel prospective single-center parallel-arm double-blinded placebo-controlled phase III randomized trial using GSH as a dietary supplement for MCI patients, while monitoring brain GSH levels and cognitive profile using non-invasive MRS and neuropsychological testing, respectively.

Considering the elevating cases of depression, obsessive-compulsive disorder, anxiety, and post-traumatic stress disorder in patients with COVID-19, scientists have been mapping brains of patients who recovered from or were asymptomatic to COVID-19. This first global study analyzed structural, spectroscopic, and behavioral changes in the brains of recovered/asymptomatic patients using a novel non-invasive MRS neuroimaging technique. Findings suggest that glutamate and GABA levels are potential parameters to monitor mental health and psychiatric disease-associated conditions. Moreover, antioxidants and neurotransmitters in the study have potential implications for psychiatric disorders in COVID-19-affected patients. [22]

Scientists studied the specific role of the human thalamus as causal outflow hub in reorganizing directed information flow and connectivity among large-scale major neurocognitive networks during brain aging. This reorganization of directed functional connectivity with age during spontaneous activity highlights the importance of subcortical areas even during stimulus independent processing. Outcomes lead to understanding the crucial role of the thalamus as a major integrative hub in addition to insular network for mediating key cognitive functional dynamics and their role during maintenance of cognitive functions during healthy aging process in the human brain. [23]

In this collaborative study, it was discovered that dengue and JE viruses activate platelet inside host and induce them release platelet factor 4 (PF4). PF4 inhibits the activity of immune cells, thus stopping interferon production. PF4 acts through its receptor CXCR3, which when blocked with an antagonist AMG487 inhibits dengue and JE replication both in vivo and in vitro. This study indicates the possibility of developing an antiviral agent. [24]

This study focused on delineating molecular mechanisms, role of miRNAs, and involvement of ZV E protein in ZV-induced microcephaly. The protein promotes premature but faulty formation of neurons, which affects normal properties of brain stem cells. This is the potential reason behind ZV-induced small head size in infants. Nearly 25 miRNAs, regulating genes and protein expression in cells, were identified as important factors impacting the cell division, proliferation and stemness of the brain stem cells. [25]

This work on focused on the regeneration of nervous system, wherein lost neuronal function was found to be restored after injury in roundworm model. The findings established that the axon fusion process has functional significance in the maintenance of neuronal integrity throughout the life span of an organism. The researchers also demonstrated how to control this process genetically for treating nerve injuries in humans in future. [26]

An active ingredient Glycyrrhizin in Mulethi (liquorice)—a commonly used herb—is a potential source for the development of a drug against COVID-19. HMGB1 is crucial for regulating susceptibility to SARS-CoV-2, whereas S-receptor binding body (RBD) and Orf3a proteins are required for maximal SARS-CoV replication and virulence. The study investigated whether Glycyrrhizin affects SARS-CoV-2 S-RBD- and Orf3a-mediated HMGB1 release and cell death in lung cells expressing SARS-CoV-2 viral proteins. Glycyrrhizin did not only reverse S-RBD- and Orf3a-induced extracellular HMGB1 release but also abrogated caspase-1 activation and rescued cell death. Benefits of anti-inflammatory properties in glycyrrhizin are: 1) Lowering the severity of the disease, 2) Mitigating viral replication by as much as 90%, and 3) Fighting the "storm of cytokines". [27]

Facilities and services

  1. Distributed Information Center (DIC): DIC is established under the initiative of BTISNET initiative of DBT. DIC manages information and communications technology (ICT) and e-governance activities of NBRC. It provides ICT science & technology services. [28]
  2. Experimental animal facility: This animal facility is registered with the Committee for the Purpose of Control and Supervision of Experiments on Animals, Ministry of Environment and Forests, Government of India, New Delhi. The facility contains animal models, including primates and transgenic mice. Detailed training programs for veterinary and husbandry care and peer-reviewed evaluation of all protocols are followed. [29]
  3. National neuroimaging facility
  4. Neuroimaging and neurospectroscopy laboratory: This laboratory functions on the metabolic analysis of different neurodegenerative disorders (e.g., AD, PD) using MRS technique to identify biomarkers in and measure quantitative stress of age-matched healthy adults and patients.
  5. Centre for Excellence for Epilepsy/MEG facility: This center studies epileptogenesis, better diagnosis, and localization of epileptogenic foci and new therapeutic techniques.
  6. Library: The library consists of automated open-access system and provides information services and access to bibliographical and full-text digital and printed resources for on-campus user community.
  7. DBT's Electronic Library Consortium (DeLCON): This is an initiative by DBT that gives unlimited access to most of the relevant periodicals to researchers. It gives access to high-quality e-resources. It provides current (1000+ online resources) and archival access to >1176 core peer-reviewed journals and one bibliographic database (SCOPUS) in different disciplines from 21 foreign publishers. [30]
  8. Speech and Language Laboratory (SALLY): Research in this lab focuses on unravelling cortical pathways involved in Hindi–English biscriptal adults and children. [31]
  9. Computational neuroscience and neuroimaging laboratory: The unit works on imaging-based diagnosis of neurodegenerative diseases and planning pulsed radiotherapy and chemotherapy for treating brain tumors from translational medicine aspect.
  10. Translational & clinical neuroscience unit: This unit provides neurological OPD services and assesses the occurrence of neurological cases in Gurgaon. Patients visiting the unit have access to several facilities, including MRI, computed tomography, etc. [32] [33]

Campus and infrastructure

Related Research Articles

<span class="mw-page-title-main">Vascular dementia</span> Dementia resulting from stroke

Vascular dementia is dementia caused by a series of strokes. Restricted blood flow due to strokes reduces oxygen and glucose delivery to the brain, causing cell injury and neurological deficits in the affected region. Subtypes of vascular dementia include subcortical vascular dementia, multi-infarct dementia, stroke-related dementia, and mixed dementia.

Cerebral atrophy is a common feature of many of the diseases that affect the brain. Atrophy of any tissue means a decrement in the size of the cell, which can be due to progressive loss of cytoplasmic proteins. In brain tissue, atrophy describes a loss of neurons and the connections between them. Brain atrophy can be classified into two main categories: generalized and focal atrophy. Generalized atrophy occurs across the entire brain whereas focal atrophy affects cells in a specific location. If the cerebral hemispheres are affected, conscious thought and voluntary processes may be impaired.

<span class="mw-page-title-main">Kalirin</span> Protein-coding gene in the species Homo sapiens

Kalirin, also known as Huntingtin-associated protein-interacting protein (HAPIP), protein duo (DUO), or serine/threonine-protein kinase with Dbl- and pleckstrin homology domain, is a protein that in humans is encoded by the KALRN gene. Kalirin was first identified in 1997 as a protein interacting with huntingtin-associated protein 1. Is also known to play an important role in nerve growth and axonal development.

Connectomics is the production and study of connectomes: comprehensive maps of connections within an organism's nervous system. More generally, it can be thought of as the study of neuronal wiring diagrams with a focus on how structural connectivity, individual synapses, cellular morphology, and cellular ultrastructure contribute to the make up of a network. The nervous system is a network made of billions of connections and these connections are responsible for our thoughts, emotions, actions, memories, function and dysfunction. Therefore, the study of connectomics aims to advance our understanding of mental health and cognition by understanding how cells in the nervous system are connected and communicate. Because these structures are extremely complex, methods within this field use a high-throughput application of functional and structural neural imaging, most commonly magnetic resonance imaging (MRI), electron microscopy, and histological techniques in order to increase the speed, efficiency, and resolution of these nervous system maps. To date, tens of large scale datasets have been collected spanning the nervous system including the various areas of cortex, cerebellum, the retina, the peripheral nervous system and neuromuscular junctions.

<span class="mw-page-title-main">Alzheimer's disease</span> Progressive neurodegenerative disease

Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, and is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation, mood swings, loss of motivation, self-neglect, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to twelve years.

Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide. To date, over 1000 scientific publications have used ADNI data. A number of other initiatives related to AD and other diseases have been designed and implemented using ADNI as a model. ADNI has been running since 2004 and is currently funded until 2021.

The Human Connectome Project (HCP) is a five-year project sponsored by sixteen components of the National Institutes of Health, split between two consortia of research institutions. The project was launched in July 2009 as the first of three Grand Challenges of the NIH's Blueprint for Neuroscience Research. On September 15, 2010, the NIH announced that it would award two grants: $30 million over five years to a consortium led by Washington University in St. Louis and the University of Minnesota, with strong contributions from University of Oxford (FMRIB) and $8.5 million over three years to a consortium led by Harvard University, Massachusetts General Hospital and the University of California Los Angeles.

Anders Martin Dale is a prominent neuroscientist and professor of radiology, neurosciences, psychiatry, and cognitive science at the University of California, San Diego (UCSD), and is one of the world's leading developers of sophisticated computational neuroimaging techniques. He is the founding Director of the Center for Multimodal Imaging Genetics (CMIG) at UCSD.

<span class="mw-page-title-main">Synaptopathy</span> Medical condition

A synaptopathy is a disease of the brain, spinal cord or peripheral nervous system relating to the dysfunction of synapses. This can arise as a result of a mutation in a gene encoding a synaptic protein such as an ion channel, neurotransmitter receptor, or a protein involved in neurotransmitter release. It can also arise as a result of an autoantibody targeting a synaptic protein. Synaptopathies caused by ion channel mutations are also known as synaptic channelopathies. An example is episodic ataxia. Myasthenia gravis is an example of an autoimmune synaptopathy. Some toxins also affect synaptic function. Tetanus toxin and botulinum toxin affect neurotransmitter release. Tetanus toxin can enter the body via a wound, and botulinum toxin can be ingested or administered therapeutically to alleviate dystonia or as cosmetic treatment.

<span class="mw-page-title-main">Resting state fMRI</span> Type of functional magnetic resonance imaging

Resting state fMRI is a method of functional magnetic resonance imaging (fMRI) that is used in brain mapping to evaluate regional interactions that occur in a resting or task-negative state, when an explicit task is not being performed. A number of resting-state brain networks have been identified, one of which is the default mode network. These brain networks are observed through changes in blood flow in the brain which creates what is referred to as a blood-oxygen-level dependent (BOLD) signal that can be measured using fMRI.

Translational neuroscience is the field of study which applies neuroscience research to translate or develop into clinical applications and novel therapies for nervous system disorders. The field encompasses areas such as deep brain stimulation, brain machine interfaces, neurorehabilitation and the development of devices for the sensory nervous system such as the use of auditory implants, retinal implants, and electronic skins.

The Rush Alzheimer's Disease Center (RADC) is an independent research center located in the Medical College of Rush University Medical Center. The Rush Alzheimer's Disease Center is one of the Alzheimer's Disease Research Centers in the U.S. designated and funded by the National Institute on Aging.

The neuroscience of aging is the study of the changes in the nervous system that occur with ageing. Aging is associated with many changes in the central nervous system, such as mild atrophy of the cortex that is considered non-pathological. Aging is also associated with many neurological and neurodegenerative disease such as amyotrophic lateral sclerosis, dementia, mild cognitive impairment, Parkinson's disease, and Creutzfeldt–Jakob disease.

<span class="mw-page-title-main">Elaine Bearer</span> American neurobiologist and pathologist

Elaine L. Bearer is an American neuroscientist, pathologist, and composer.

Nihar Ranjan Jana is an Indian neuroscientist and professor at the IIT Kharagpur, known for his studies on E3 ubiquitin ligases, protein homeostasis and neurodegenerative disorders. Jana is an elected fellow of the National Academy of Sciences, India. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, in 2008 and TATA Innovation Fellowship in 2014 for his contributions to Neurodegenerative diseases.

<span class="mw-page-title-main">Limbic-predominant age-related TDP-43 encephalopathy</span> (LATE) -- a form of dementia

LATE is a term that describes a prevalent medical condition with impaired memory and thinking in advanced age, often culminating in the dementia clinical syndrome. In other words, the symptoms of LATE are similar to those of Alzheimer's disease. 

Heather Clare Whalley is a Scottish scientist. She is a Professor of Neuroscience and Mental Health neuroimaging at the Centre for Clinical Brain Sciences, University of Edinburgh, and is an affiliate member of the Centre for Genomic and Experimental Medicine at the University of Edinburgh. Her main focus of research is on the mechanisms underlying the development of major psychiatric disorders using the latest genomic and neuroimaging approaches.

<span class="mw-page-title-main">Aloxistatin</span> Chemical compound

Aloxistatin is a drug which acts as a cysteine protease inhibitor and has anticoagulant effects. It is a synthetic analogue of E-64, a natural product derived from fungi. It was researched for the treatment of muscular dystrophy but was not successful in human clinical trials, though it has continued to be investigated for treatment of spinal cord injury, stroke and Alzheimer's disease.

<span class="mw-page-title-main">Neurovascular unit</span>

The neurovascular unit (NVU) comprises the components of the brain that collectively regulate cerebral blood flow in order to deliver the requisite nutrients to activated neurons. The NVU addresses the brain's unique dilemma of having high energy demands yet low energy storage capacity. In order to function properly, the brain must receive substrates for energy metabolism–mainly glucose–in specific areas, quantities, and times. Neurons do not have the same ability as, for example, muscle cells, which can use up their energy reserves and refill them later; therefore, cerebral metabolism must be driven in the moment. The neurovascular unit facilitates this ad hoc delivery and, thus, ensures that neuronal activity can continue seamlessly.

References

  1. ↑ Dbt_Institutions
  2. ↑ Archived 17 December 2009 at the Wayback Machine
  3. ↑ "DBT - Department of Biotechnology". Dbtindia.nic.in. 14 November 1997. Archived from the original on 17 April 2012. Retrieved 15 March 2012.
  4. ↑ Jyoti, Archana. "A new tool for testing dyslexia". natureasia. Nature. doi:10.1038/nindia.2019.118 (inactive 1 November 2024). Retrieved 22 September 2021.{{cite web}}: CS1 maint: DOI inactive as of November 2024 (link)
  5. ↑ Mandal, Pravat Kumar (2 March 2020). "KALPANA: Advanced Spectroscopic Signal Processing Platform for Improved Accuracy to Aid in Early Diagnosis of Brain Disorders in Clinical Setting". Journal of Alzheimer's Disease. 75 (2): 397–402. doi:10.3233/JAD-191351. PMID   32200359. S2CID   214617533.
  6. ↑ Roy, Sourav. "NINS-STAT: An Automated Statistical Software Package". NINS-STAT. NBRC. Retrieved 22 September 2021.
  7. ↑ Mandal, Pravat Kumar. "New tool to decode brain images of Indians". natureindia. Springer Nature. doi:10.1038/nindia.2020.45 (inactive 1 November 2024). Retrieved 22 September 2021.{{cite web}}: CS1 maint: DOI inactive as of November 2024 (link)
  8. ↑ Pai, Praful (July 2020). "BRAHMA: Population specific T1, T2, and FLAIR weighted brain templates and their impact in structural and functional imaging studies". Magnetic Resonance Imaging. 70: 5–21. doi:10.1016/j.mri.2019.12.009. PMID   31917995. S2CID   210133704 . Retrieved 22 September 2021.
  9. ↑ Mandal, Pravat Kumar. "BRAHMA: The Indian Brain Template". BRAHMA. NBRC. Retrieved 22 September 2021.
  10. ↑ Sharma, Ankita (8 February 2019). "BHARAT: An Integrated Big Data Analytic Model for Early Diagnostic Biomarker of Alzheimer's Disease". Frontiers in Neurology. 10 (9): 9. doi: 10.3389/fneur.2019.00009 . PMC   6375828 . PMID   30800093.
  11. ↑ Goel, Anshika (July 2021). "PRATEEK: Integration of Multimodal Neuroimaging Data to Facilitate Advanced Brain Research". Journal of Alzheimer's Disease. 83 (1): 305–317. doi:10.3233/JAD-210440. PMID   34308905. S2CID   236429869 . Retrieved 22 September 2021.
  12. ↑ Mandal, Pravat Kumar (2021). "PRATEEK: Integration of Multimodal Neuroimaging Data to Facilitate Advanced Brain Research". Journal of Alzheimer's Disease. 83 (1). nbrc: 305–317. doi:10.3233/JAD-210440. PMID   34308905. S2CID   236429869 . Retrieved 22 September 2021.
  13. ↑ Mandal, Pravat Kumar. "STIM: Functional MRI Paradigm Design, Presentation, and Response Collection System". STIM. NBRC. Retrieved 22 September 2021.
  14. ↑ Sheriff, Ahmed (27 April 2018). "Artificial Intelligence For Early Detection of Alzheimer's? Indian Scientists Say Yes!". Community at the better india. the better india. Retrieved 22 September 2021.
  15. ↑ Mandal, Pravat Kumar. "GAURI: A Method and a System Using Multi-modal Information for Early Detection of Alzheimer's Disease". GAURI. NBRC. Retrieved 22 September 2021.
  16. ↑ Mandal, Pravat Kumar. "New database to advance global Alzheimer's research". natureindia. Nature Springer. doi:10.1038/nindia.2020.175 (inactive 1 November 2024). Retrieved 22 September 2021.{{cite web}}: CS1 maint: DOI inactive as of November 2024 (link)
  17. ↑ Mandal, Pravat Kumar (7 October 2021). "ANSH: Multimodal Neuroimaging Database Including MR Spectroscopic Data From Each Continent to Advance Alzheimer's Disease Research". Frontiers in Neuroinformatics. 14: 571039. doi: 10.3389/fninf.2020.571039 . PMC   7641007 . PMID   33214792 . Retrieved 22 September 2021.
  18. ↑ Mandal, Pravat Kumar. "SWADESH: Comprehensive Database and Data Analytics for Brain Research". SWADESH. NBRC. Retrieved 22 September 2021.
  19. ↑ Shukla, Deepika (September 2021). "Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MR Spectroscopic Study". Journal of Alzheimer's Disease. 84 (3): 1139–1152. doi:10.3233/JAD-215032. PMID   34633325. S2CID   238580011 . Retrieved 22 September 2021.
  20. ↑ Mandal, Pravat Kumar (13 January 2021). "Hippocampal pH rise towards alkalinity: A perfect storm for Alzheimer's disease". npj Science of Learning. Retrieved 22 September 2021.
  21. ↑ Shukla, Deepika (30 October 2018). "A Multi-Center Study on Human Brain Glutathione Conformation using Magnetic Resonance Spectroscopy". IOS Press Content Library. 66 (2): 517–532. doi:10.3233/JAD-180648. PMC   6218146 . PMID   30198874.
  22. ↑ Samkaria, Avantika (14 September 2021). "Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring". Journal of Alzheimer's Disease. 83 (2): 523–530. doi: 10.3233/JAD-210287 . PMID   34250939. S2CID   235798017.
  23. ↑ Das, Moumita (30 November 2020). "Reconfiguration of Directed Functional Connectivity Among Neurocognitive Networks with Aging: Considering the Role of Thalamo-Cortical Interactions". Cerebral Cortex. 31 (4): 1970–1986. doi:10.1093/cercor/bhaa334. PMC   7945028 . PMID   33253367.
  24. ↑ Sharma, Yogesh. "Scientists identify protein that helps dengue and JE viruses to multiply". India Science Wire. Vigyan Prasar. Retrieved 22 September 2021.
  25. ↑ Bhagat, Reshma (26 July 2018). "Zika virus E protein alters the properties of human fetal neural stem cells by modulating microRNA circuitry". Cell Death and Differentiation. 25 (10): 1837–1854. doi:10.1038/s41418-018-0163-y. PMC   6180120 . PMID   30050059.
  26. ↑ Basu, Atrayee (21 November 2017). "let-7 miRNA controls CED-7 homotypic adhesion and EFF-1–mediated axonal self-fusion to restore touch sensation following injury". PNAS. 114 (47): E10206–E10215. Bibcode:2017PNAS..11410206B. doi: 10.1073/pnas.1704372114 . PMC   5703274 . PMID   29109254.
  27. ↑ Gowda, Pruthvi (June 2021). "Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication". Cytokine. 142: 155496. doi:10.1016/j.cyto.2021.155496. PMC   7953444 . PMID   33773396.
  28. ↑ "BTISNET - Distributed Information Centre". Biotechnology Information System Network. Department of Biotechnology. Retrieved 23 September 2021.
  29. ↑ "National Brain Research Centre". Educationworld. 24 July 2015. Retrieved 23 September 2021.
  30. ↑ "DeLCON". DeLCON DBT e-Library Consortium. Department of Biotechnology. Retrieved 23 September 2021.
  31. ↑ "BTISNET - Distributed Information Centre". Biotechnology Information System Network. Retrieved 23 September 2021.
  32. ↑ "NBRC Gurgaon Facilities". CAREERS360. Retrieved 23 September 2021.
  33. ↑ "Facilities". National Brain Research Centre. Retrieved 23 September 2021.
  34. ↑ "National Brain Research Centre - NBRC". Target Study. Retrieved 23 September 2021.
  35. ↑ "Life at NBRC". National Brain Research Centre. Retrieved 23 September 2021.
  36. ↑ "National Brain Research Centre Manesar IN-HR". eBird. Retrieved 23 September 2021.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.